Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors

Journal of Clinical Oncology

Volumn 21, Issue 5, 2003, Pages 871-877

  Christian, J A ^a   Huddart, R A ^a   Norman, A ^a   Mason, M ^a   Fossa, S ^a   Aass, N ^a   Nicholl, E J ^a   Dearnaley, D P ^a   Horwich, A ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; VINCRISTINE; ANTINEOPLASTIC AGENT; BEP PROTOCOL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RELAPSE; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FOLLOW UP; HUMAN; MALE; MEDIASTINUM TUMOR; NON SEMINOMATOUS GERMINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TESTIS TUMOR; TREATMENT OUTCOME; ADOLESCENT; ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; GERM CELL TUMOR; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; REMISSION; REVIEW; SURVIVAL RATE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; GERMINOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION; SURVIVAL RATE; TESTICULAR NEOPLASMS; VINCRISTINE;

EID: 0037364734     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.05.155     Document Type: Article

References (25)

1. International Germ Cell Cancer Collaborative Group: International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594-603, 1997
2. Bower M, Newlands ES, Holden L, et al: Treatment of men with metastatic nonseminomatous germ cell tumors with cyclical POMB/ACE chemotherapy. Ann Oncol 8:477-483, 1997
3. Nichols CR, Catalano PJ, Crawford ED, et al: Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. J Clin Oncol 16:1287-1293, 1998
4. Chevreau C, Droz JP, Pico JL, et al: Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk nonseminomatous germ cell tumors: Preliminary results of a French randomized trial. Eur Urol 23:213-217, 1993
5. Malaise EP, Chavaudra N, Charbit A: Relationship between the growth rate of human metastases, survival and pathological type. Eur J Cancer 10:451-459, 1974
6. Price P, Hogan SJ, Horwich A: The growth rate of metastatic nonseminomatous germ cell testicular tumors measured by marker production doubling time: I. Theoretical basis and practical application (erratum appears in Eur J Cancer 26:925, 1990). Eur J Cancer 26:450-453, 1990
7. Fossa SD, Pettersen EO, Thorud E, et al: DNA flow cytometry in human testicular cancer. Cancer Lett 28:55-60, 1985
8. Silvestrini R, Costa A, Pilotti S, et al: Cell kinetics in human germ call tumors of the testis, in Pavone-Macaluso M, Smith PH, Bagshaw MA (eds): Testicular Cancer and Other Tumors of the Genitourinary Tract. New York, NY, Plenum, 1985, pp 55-62
9. Rabes HM: Proliferation of human testicular tumors. Int J Androl 10:127-137, 1987
10. Withers HR, Taylor JM, Maciejewski B: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131-146, 1988
11. Dearnaley DP: Intensive induction chemotherapy for poor risk tumors, in Horwich A (ed): Testicular Cancer, Investigation and Management (ed 2). London, United Kingdom, Chapman & Hall, 1996, pp 271-285
12. Horwich A, Brada M, Nicholls J, et al: Intensive induction chemotherapy for poor risk nonseminomatous germ cell tumors. Eur J Cancer Clin Oncol 25:177-184, 1989
13. Samuels ML, Holoye PY, Johnson DE: Bleomycin combination chemotherapy in the management of testicular neoplasia. Cancer 36:318-326, 1975
14. Gerson R, Tellez BE, Lazaro LM, et al: Low toxicity with continuous infusion of high-dose bleomycin in poor prognostic testicular cancer. Am J Clin Oncol 16:323-326, 1993
15. Horwich A, Dearnaley DP, Norman A, et al: Accelerated chemotherapy for poor prognosis germ cell tumors. Eur J Cancer 30A:1607-1611, 1994
16. Mead GM, Stenning SP, Parkinson MC, et al: The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors: Medical Research Council Testicular Tumor Working Party. J Clin Oncol 10:85-94, 1992
17. Peckham MJ: Investigations and staging: General aspects and staging classification, in Peckham MJ (ed): The Management of Testicular Tumours, Edward Arnold, London, 1981, p 89-101
18. Calvert AH, Newell DR, Gumbrell LA, et al: Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 7:1748-1756, 1989
19. Dearnaley DP, Nicholl J, Saunders M: BEP chemotherapy for metastatic teratoma: Royal Marsden experience 1979-1986. Br J Cancer 58:526, 1988 (abstr)
20. Wettlaufer JN, Feiner AS, Robinson WA: Vincristine, cisplatin and bleomycin with surgery in the management of advanced metastatic nonseminomatous testis tumors. Cancer 53:203-209, 1984
21. Murray N, Coppin C, Swenerton K: Weekly high intensity cisplatin etoposide (HIPE) for far advanced germ cell cancers (GCC). Proc Am Soc Clin Oncol 6:101, 1987 (abstr 394)
22. Kaye SB, Mead GM, Fossa S, et al: Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: A Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study. J Clin Oncol 16:692-701, 1998
23. Lewis CR, Fossa SD, Mead G, et al: BOP/VIP-A new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumors. Ann Oncol 2:203-211, 1991
24. Bokemeyer C, Kollmannsberger C, Meisner C, et al: First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis. J Clin Oncol 17:3450-3456, 1999
25. O'Sullivan JM, Huddart RA, Norman AR, et al: Predicting the risk of bleomycin lung toxicity in patients with germ cell tumors. Ann Oncol 14:91-96, 2003